80_FR_52456 80 FR 52289 - Proposed Data Collections Submitted for Public Comment and Recommendations [email protected]"> [email protected]" /> [email protected]" />

80 FR 52289 - Proposed Data Collections Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 167 (August 28, 2015)

Page Range52289-52291
FR Document2015-21345

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the proposed extension of the information collection entitled The Gonococcal Isolate Surveillance Project (GISP), which is the only source in the United States of national, regional, and site-specific gonococcal antibiotic resistance information that provides information to support informed and scientifically-based treatment recommendations. To request more information on the below proposed project or to obtain a copy of the information collection plan and instruments, call 404-639-7570 or send comments to Leroy A. Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an email to [email protected]

Federal Register, Volume 80 Issue 167 (Friday, August 28, 2015) 
[Federal Register Volume 80, Number 167 (Friday, August 28, 2015)]
[Notices]
[Pages 52289-52291]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-21345]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-15-0307; Docket No. CDC-2015-0072]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

AGENCY: The Centers for Disease Control and Prevention (CDC).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies to take this opportunity to comment on proposed and/or 
continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on the proposed 
extension of the information collection entitled The Gonococcal Isolate 
Surveillance Project (GISP), which is the only source in the United 
States of national, regional, and site-specific gonococcal antibiotic 
resistance information that provides information to support informed 
and scientifically-based treatment recommendations.
    To request more information on the below proposed project or to 
obtain a copy of the information collection plan and instruments, call 
404-639-7570 or send comments to Leroy A. Richardson, 1600 Clifton 
Road, MS-D74, Atlanta, GA 30333 or send an email to omb@cdc.gov.

DATES: Written comments must be received on or before October 27, 2015.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2015-
0072 by any of the following methods:
     Federal eRulemaking Portal: Regulation.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.

    Please note:  All public comment should be submitted through the 
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the 
address listed above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying information, processing and 
maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information, to search data sources, to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information.

Proposed Project

    The Gonococcal Isolate Surveillance Project (GISP), (OMB No.0920-
0307 exp. 08/31/2016)--Extension--National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention (NCHHSTP),

[[Page 52290]]

Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The objectives of GISP are: (1) To monitor trends in antibiotic 
resistance of Neisseria gonorrhoeae strains in the United States and 
(2) to characterize resistant specimens. Surveillance of N. gonorrhoeae 
antibiotic resistance is important because: (1) Nearly all gonococcal 
infections are treated empirically (meaning that healthcare providers 
have to decide how to treat their patients without having resistance 
testing results for individual patients upon which to base clinical 
decision-making) and susceptibility/resistance testing data are not 
routinely available in clinical practice; (2) N. gonorrhoeae has 
consistently demonstrated the ability to develop resistance to the 
antibiotics used for treatment; (3) effective treatment of gonorrhea is 
a critical component of gonorrhea control and prevention, and (4) 
untreated or inadequately treated gonorrhea can cause serious 
reproductive health complications.
    GISP is the only source in the United States of national, regional, 
and site-specific gonococcal antibiotic resistance information. GISP 
provides information to support informed and scientifically-based 
treatment recommendations.
    GISP was established in 1986 as a voluntary surveillance project 
and now involves 5 regional laboratories and 30 publicly funded 
sexually transmitted disease (STD) clinics around the country. The STD 
clinics submit up to 25 gonococcal specimens (or isolates) per month to 
the regional laboratories, which measure the ability of the specimens 
to resist the effects of multiple antibiotics. Limited demographic and 
clinical information corresponding to the isolates (and that do not 
allow identification of the patient) are submitted directly by the 
clinics to CDC.
    During 1986-2015, GISP has demonstrated the ability to effectively 
achieve its objectives. The emergence of resistance in the United 
States to penicillin, tetracyclines, and fluoroquinolones among N. 
gonorrhoeae isolates was identified through GISP. Increased prevalence 
of fluoroquinolone-resistant N. gonorrhoeae (QRNG), as documented by 
GISP data, prompted CDC to update treatment recommendations for 
gonorrhea in CDC's Sexually Transmitted Diseases Treatment Guidelines, 
2006 and to release an MMWR article stating that CDC no longer 
recommended fluoroquinolones for treatment of gonococcal infections. 
Information from GISP thus allowed public health officials to change 
treatment recommendations before resistance became widespread, ensuring 
that patients were able to be successfully treated. Recently, GISP 
isolates demonstrated increasing minimum inhibitory concentrations of 
cefixime, which can be an early warning of impending resistance. This 
worrisome trend prompted CDC to again update treatment recommendations 
and no longer recommend the use of cefixime as first-line treatment for 
gonococcal infections.
    Under the GISP protocol, each of the 30 clinics submit an average 
of 20 isolates per clinic per month (i.e. 240 times per year) recorded 
on Form 1: Demographic/Clinical Data. The estimated time for clinical 
personnel to abstract data for Form 1: Demographic/Clinical Data is 11 
minutes per response.
    Each of the five Regional laboratories receives and processes an 
approximately 20 isolates from each referring clinic per month (i.e. 
121 isolates per regional laboratory per month [based on 2011 specimen 
volume]) using Form 2: Antimicrobial Susceptibility Testing. For Form 
2: Antimicrobial Susceptibility Testing, the annual frequency of 
responses per respondent is 1,452 (121 isolates x 12 months). Based on 
previous laboratory experience, the estimated burden of completing Form 
2 for each participating laboratory is 1 hour per response, which 
includes the time required for laboratory processing of the patient's 
isolate, gathering and maintaining the data needed, and completing and 
reviewing the collection of information. For Form 3: Control Strain 
Susceptibility Testing, a ``response'' is defined as the processing and 
recording of Regional laboratory data for a set of seven control 
strains. It takes approximately 12 minutes to process and record the 
Regional laboratory data on Form 3 for one set of seven control 
strains, of which there are 4 sets. The number of responses per 
respondent is 48 (4 sets x 12 months).
    The total estimated annual burden hours are 8,628. Respondents 
receive federal funds to participate in this project. There are no 
additional costs to respondents other than their time.

                                       Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden   Total annual
      Type of respondents           Form name        Number of     responses per   per response     burden (in
                                                    respondents     respondent      (in hours)        hours)
----------------------------------------------------------------------------------------------------------------
Clinic........................  Demographic                   30             240           11/60           1,320
                                 Clinical Data
                                 Form 1.
Laboratory....................  Antimicrobial                  5           1,452               1           7,260
                                 Susceptibility
                                 Testing Form 2.
                                Control Strain                 5              48           12/60              48
                                 Susceptibility
                                 Testing Form 3.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           8,628
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-21345 Filed 8-27-15; 8:45 am]
 BILLING CODE 4163-18-P

Federal Register / Vol. 80, No. 167 / Friday, August 28, 2015 / Notices 52289 ESTIMATED ANNUALIZED BURDEN HOURS Average Number of Number of burden per Total burden Type of respondents Form name responses per respondents response (in hrs.) respondent (in hrs.) Households ................................ Paper-based questionnaire ..................... 1,215 1 12/60 243 Households ................................ Web-based questionnaire ....................... 810 1 12/60 162 Utility employees ........................ Household listing ..................................... 6 5 3 90 Utility employees ........................ Water sample collection (grab samples) 6 3 130/60 39 Utility employees ........................ Water sample collection (ultrafiltration 6 2 30/60 6 samples). Utility employees ........................ Low pressure event form ........................ 6 5 15/60 8 Total .................................... ................................................................. ........................ ........................ ........................ 548 Leroy A. Richardson, GA 30333 or send an email to omb@ information, and each reinstatement of Chief, Information Collection Review Office, cdc.gov. previously approved information Office of Scientific Integrity, Office of the collection before submitting the DATES: Written comments must be Associate Director for Science, Office of the collection to OMB for approval. To Director, Centers for Disease Control and received on or before October 27, 2015. ADDRESSES: You may submit comments, comply with this requirement, we are Prevention. identified by Docket No. CDC–2015– publishing this notice of a proposed [FR Doc. 2015–21346 Filed 8–27–15; 8:45 am] data collection as described below. BILLING CODE 4163–18–P 0072 by any of the following methods: • Federal eRulemaking Portal: Comments are invited on: (a) Whether Regulation.gov. Follow the instructions the proposed collection of information DEPARTMENT OF HEALTH AND for submitting comments. is necessary for the proper performance HUMAN SERVICES • Mail: Leroy A. Richardson, of the functions of the agency, including Information Collection Review Office, whether the information shall have Centers for Disease Control and Centers for Disease Control and practical utility; (b) the accuracy of the Prevention Prevention, 1600 Clifton Road NE., MS– agency’s estimate of the burden of the D74, Atlanta, Georgia 30329. proposed collection of information; (c) [60Day–15–0307; Docket No. CDC–2015– Instructions: All submissions received 0072] ways to enhance the quality, utility, and must include the agency name and clarity of the information to be Proposed Data Collections Submitted Docket Number. All relevant comments collected; (d) ways to minimize the for Public Comment and received will be posted without change burden of the collection of information Recommendations to Regulations.gov, including any on respondents, including through the personal information provided. For use of automated collection techniques AGENCY: The Centers for Disease Control access to the docket to read background or other forms of information and Prevention (CDC). documents or comments received, go to technology; and (e) estimates of capital ACTION: Notice with comment period. Regulations.gov. or start-up costs and costs of operation, SUMMARY: The Centers for Disease Please note: All public comment should be maintenance, and purchase of services submitted through the Federal eRulemaking to provide information. Burden means Control and Prevention (CDC), as part of portal (Regulations.gov) or by U.S. mail to the its continuing effort to reduce public the total time, effort, or financial address listed above. resources expended by persons to burden and maximize the utility of government information, invites the FOR FURTHER INFORMATION CONTACT: To generate, maintain, retain, disclose or general public and other Federal request more information on the provide information to or for a Federal agencies to take this opportunity to proposed project or to obtain a copy of agency. This includes the time needed comment on proposed and/or the information collection plan and to review instructions; to develop, continuing information collections, as instruments, contact the Information acquire, install and utilize technology required by the Paperwork Reduction Collection Review Office, Centers for and systems for the purpose of Act of 1995. This notice invites Disease Control and Prevention, 1600 collecting, validating and verifying comment on the proposed extension of Clifton Road NE., MS–D74, Atlanta, information, processing and the information collection entitled The Georgia 30329; phone: 404–639–7570; maintaining information, and disclosing Gonococcal Isolate Surveillance Project Email: omb@cdc.gov. and providing information; to train (GISP), which is the only source in the SUPPLEMENTARY INFORMATION: Under the personnel and to be able to respond to United States of national, regional, and Paperwork Reduction Act of 1995 (PRA) a collection of information, to search site-specific gonococcal antibiotic (44 U.S.C. 3501–3520), Federal agencies data sources, to complete and review resistance information that provides must obtain approval from the Office of the collection of information; and to information to support informed and Management and Budget (OMB) for each transmit or otherwise disclose the scientifically-based treatment collection of information they conduct information. Lhorne on DSK5TPTVN1PROD with NOTICES recommendations. or sponsor. In addition, the PRA also Proposed Project To request more information on the requires Federal agencies to provide a below proposed project or to obtain a 60-day notice in the Federal Register The Gonococcal Isolate Surveillance copy of the information collection plan concerning each proposed collection of Project (GISP), (OMB No.0920–0307 and instruments, call 404–639–7570 or information, including each new exp. 08/31/2016)—Extension—National send comments to Leroy A. Richardson, proposed collection, each proposed Center for HIV/AIDS, Viral Hepatitis, 1600 Clifton Road, MS–D74, Atlanta, extension of existing collection of STD, and TB Prevention (NCHHSTP), VerDate Sep<11>2014 14:19 Aug 27, 2015 Jkt 235001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\28AUN1.SGM 28AUN1

52290 Federal Register / Vol. 80, No. 167 / Friday, August 28, 2015 / Notices Centers for Disease Control and which measure the ability of the isolates per clinic per month (i.e. 240 Prevention (CDC). specimens to resist the effects of times per year) recorded on Form 1: multiple antibiotics. Limited Demographic/Clinical Data. The Background and Brief Description demographic and clinical information estimated time for clinical personnel to The objectives of GISP are: (1) To corresponding to the isolates (and that abstract data for Form 1: Demographic/ monitor trends in antibiotic resistance do not allow identification of the Clinical Data is 11 minutes per of Neisseria gonorrhoeae strains in the patient) are submitted directly by the response. United States and (2) to characterize clinics to CDC. Each of the five Regional laboratories resistant specimens. Surveillance of N. During 1986–2015, GISP has receives and processes an gonorrhoeae antibiotic resistance is demonstrated the ability to effectively approximately 20 isolates from each important because: (1) Nearly all achieve its objectives. The emergence of referring clinic per month (i.e. 121 gonococcal infections are treated resistance in the United States to isolates per regional laboratory per empirically (meaning that healthcare penicillin, tetracyclines, and month [based on 2011 specimen providers have to decide how to treat fluoroquinolones among N. gonorrhoeae volume]) using Form 2: Antimicrobial their patients without having resistance isolates was identified through GISP. Susceptibility Testing. For Form 2: testing results for individual patients Increased prevalence of Antimicrobial Susceptibility Testing, upon which to base clinical decision- fluoroquinolone-resistant N. the annual frequency of responses per making) and susceptibility/resistance gonorrhoeae (QRNG), as documented by respondent is 1,452 (121 isolates × 12 testing data are not routinely available GISP data, prompted CDC to update months). Based on previous laboratory in clinical practice; (2) N. gonorrhoeae treatment recommendations for experience, the estimated burden of has consistently demonstrated the gonorrhea in CDC’s Sexually completing Form 2 for each ability to develop resistance to the Transmitted Diseases Treatment participating laboratory is 1 hour per antibiotics used for treatment; (3) Guidelines, 2006 and to release an response, which includes the time effective treatment of gonorrhea is a MMWR article stating that CDC no required for laboratory processing of the critical component of gonorrhea control longer recommended fluoroquinolones patient’s isolate, gathering and and prevention, and (4) untreated or for treatment of gonococcal infections. maintaining the data needed, and inadequately treated gonorrhea can Information from GISP thus allowed completing and reviewing the collection cause serious reproductive health public health officials to change of information. For Form 3: Control complications. treatment recommendations before Strain Susceptibility Testing, a GISP is the only source in the United resistance became widespread, ensuring ‘‘response’’ is defined as the processing States of national, regional, and site- that patients were able to be and recording of Regional laboratory specific gonococcal antibiotic resistance successfully treated. Recently, GISP data for a set of seven control strains. It information. GISP provides information isolates demonstrated increasing takes approximately 12 minutes to to support informed and scientifically- minimum inhibitory concentrations of process and record the Regional based treatment recommendations. cefixime, which can be an early warning laboratory data on Form 3 for one set of GISP was established in 1986 as a of impending resistance. This seven control strains, of which there are voluntary surveillance project and now worrisome trend prompted CDC to again 4 sets. The number of responses per involves 5 regional laboratories and 30 update treatment recommendations and respondent is 48 (4 sets × 12 months). publicly funded sexually transmitted no longer recommend the use of The total estimated annual burden disease (STD) clinics around the cefixime as first-line treatment for hours are 8,628. Respondents receive country. The STD clinics submit up to gonococcal infections. federal funds to participate in this 25 gonococcal specimens (or isolates) Under the GISP protocol, each of the project. There are no additional costs to per month to the regional laboratories, 30 clinics submit an average of 20 respondents other than their time. ESTIMATE OF ANNUALIZED BURDEN HOURS Average Number of Total annual Number of burden per Type of respondents Form name responses per burden respondents response respondent (in hours) (in hours) Clinic ................................................. Demographic Clinical Data Form 1 .. 30 240 11/60 1,320 Laboratory ......................................... Antimicrobial Susceptibility Testing 5 1,452 1 7,260 Form 2. Control Strain Susceptibility Testing 5 48 12/60 48 Form 3. Total ........................................... ........................................................... ........................ ........................ ........................ 8,628 Leroy A. Richardson, Chief, Information Collection Review Office, Lhorne on DSK5TPTVN1PROD with NOTICES Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2015–21345 Filed 8–27–15; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 16:41 Aug 27, 2015 Jkt 235001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\28AUN1.SGM 28AUN1

Federal Register / Vol. 80, No. 167 / Friday, August 28, 2015 / Notices 52291 DEPARTMENT OF HEALTH AND Clifton Road NE., MS–D74, Atlanta, (CLAS) Survey—New—National Center HUMAN SERVICES Georgia 30329; phone: 404–639–7570. for Health Statistics (NCHS), Centers for SUPPLEMENTARY INFORMATION: Under the Disease Control and Prevention (CDC). Centers for Disease Control and Paperwork Reduction Act of 1995 (PRA) Prevention Background and Brief Description (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of As the population of the United States [60Day–15–15BCU; Docket No. CDC–2015– 0074] Management and Budget (OMB) for each becomes increasingly diverse, it is collection of information they conduct important that health care providers Proposed Data Collections Submitted or sponsor. In addition, the PRA also deliver culturally and linguistically for Public Comment and requires Federal agencies to provide a competent services. Culturally and Recommendations 60-day notice in the Federal Register linguistically appropriate services concerning each proposed collection of (CLAS) are respectful of and responsive AGENCY: Centers for Disease Control and to individual cultural health beliefs and information, including each new Prevention (CDC), Department of Health practices, preferred languages, health proposed collection, each proposed and Human Services (HHS). literacy levels, and communication extension of existing collection of ACTION: Notice with comment period. information, and each reinstatement of needs. The National CLAS Standards in previously approved information Health and Health Care were established SUMMARY: The Centers for Disease in 2000 by the Office of Minority Health collection before submitting the Control and Prevention (CDC), as part of (OMH), Department of Health and collection to OMB for approval. To its continuing effort to reduce public Human Services (DHHS) to advance comply with this requirement, we are burden and maximize the utility of health equity, improve quality, and publishing this notice of a proposed government information, invites the eliminate health care disparities. In data collection as described below. general public and other Federal 2013, OMH published the Enhanced agencies to take this opportunity to Comments are invited on: (a) Whether the proposed collection of information Standards for CLAS in Health and comment on proposed and/or Health Care to revise the National CLAS continuing information collections, as is necessary for the proper performance of the functions of the agency, including Standards in order to reflect required by the Paperwork Reduction advancements made since 2000, expand Act of 1995. This notice invites whether the information shall have practical utility; (b) the accuracy of the their scope and improve their clarity to comment on the National Ambulatory ensure better understanding and Medical Care Survey (NAMCS) on agency’s estimate of the burden of the proposed collection of information; (c) implementation. Although there has Culturally and Linguistically been increased awareness and efforts to Appropriate Services (CLAS) Survey. ways to enhance the quality, utility, and clarity of the information to be train culturally and linguistically The purpose of the NAMCS CLAS competent health care providers, there survey is to describe the awareness, collected; (d) ways to minimize the burden of the collection of information has not been a systematic evaluation of training, adoption, and implementation the level of adoption or implementation of the Enhanced Standards for CLAS in on respondents, including through the use of automated collection techniques of the National CLAS Standards among Health and Health Care among office- physicians. Due to the limited based physicians. or other forms of information technology; and (e) estimates of capital understanding of how the Standards are DATES: Written comments must be adopted and implemented, it is difficult or start-up costs and costs of operation, received on or before October 27, 2015. maintenance, and purchase of services to know what goals have been achieved ADDRESSES: You may submit comments, to provide information. Burden means and which need more work. identified by Docket No. CDC–2015– the total time, effort, or financial OMH came to NCHS’ Division of 0074 by any of the following methods: resources expended by persons to Health Care Statistics with this project • Federal eRulemaking Portal: generate, maintain, retain, disclose or because of our expertise collecting data Regulations.gov. Follow the instructions provide information to or for a Federal from physicians in the NAMCS. The for submitting comments. agency. This includes the time needed NAMCS CLAS project meets two of the • Mail: Leroy A. Richardson, to review instructions; to develop, Division’s missions: Conduct Information Collection Review Office, acquire, install and utilize technology multidisciplinary research directed Centers for Disease Control and and systems for the purpose of towards development of new scientific Prevention, 1600 Clifton Road NE., MS– collecting, validating and verifying knowledge on the provision, use, D74, Atlanta, Georgia 30329. information, processing and quality, and appropriateness of Instructions: All submissions received maintaining information, and disclosing ambulatory care; and develop and must include the agency name and and providing information; to train sustain collaborative partnerships Docket Number. All relevant comments personnel and to be able to respond to internally within DHHS and externally received will be posted without change a collection of information, to search with public, private, domestic and to Regulations.gov, including any data sources, to complete and review international entities on health care personal information provided. For the collection of information; and to statistics programs. The purpose of the access to the docket to read background transmit or otherwise disclose the NAMCS CLAS survey is to describe the documents or comments received, go to information. awareness, training, adoption, and Regulations.gov. implementation of the Enhanced Lhorne on DSK5TPTVN1PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Proposed Project Standards for CLAS in Health and Leroy A. Richardson, Information National Ambulatory Medical Care Health Care among office-based Collection Review Office, Centers for Survey (NAMCS) on Culturally and physicians. The information will be Disease Control and Prevention,1600 Linguistically Appropriate Services collected directly from physician VerDate Sep<11>2014 16:41 Aug 27, 2015 Jkt 235001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\28AUN1.SGM 28AUN1


Document Created: 2015-12-15 11:04:42
Document Modified: 2015-12-15 11:04:42
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice with comment period.
DatesWritten comments must be received on or before October 27, 2015.
ContactTo request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS- D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected]
FR Citation80 FR 52289 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR